Paclitaxel binds to β-tubulin to exert its cytotoxic effect and genetic variants within the promoter of TUBB2A have previously been shown to be associated with increased expression of the gene and reduced risk of paclitaxel-induced peripheral neuropathy [28]. Here, TUBB2A is linked to peripheral neuropathy.